This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
$69.64
Share price
0.00%
Change (1 day)
33.21%
Change (1 year)
Categories
EPS for ChemoCentryx (CCXI)
EPS in 2022 (TTM): -$2.58
According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -$2.53. In 2021 the company made an earnings per share (EPS) of -$2.53 a decrease over its 2020 EPS that were of -$1.09.
EPS history for ChemoCentryx from 2012 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | -$2.58 | 1.76% |
| 2021 | -$2.53 | 133.33% |
| 2020 | -$1.09 | -16.49% |
| 2019 | -$1.30 | 27.63% |
| 2018 | -$1.02 | -305.41% |
| 2017 | $0.50 | -142.53% |
| 2016 | -$1.17 | -19.44% |
| 2015 | -$1.45 | -0% |
| 2014 | -$1.45 | 13.68% |
| 2013 | -$1.27 | -16.67% |
| 2012 | -$1.53 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | $24.73 | -1,076.72% | 🇺🇸 USA |
 | $4.93 | -294.74% | 🇺🇸 USA |
 | $4.69 | -285.22% | 🇬🇧 UK |
 | $5.32 | -310.05% | 🇺🇸 USA |
 | $18.87 | -845.25% | 🇺🇸 USA |
 | $18.95 | -848.68% | 🇺🇸 USA |
 | $2.49 | -198.41% | 🇺🇸 USA |
 | -$2.68 | 5.82% | 🇮🇱 Israel |
 | $2.44 | -196.39% | 🇺🇸 USA |